UK-based software company New Wave Biotech has entered into a commercial partnership with Singapore’s Nurasa to integrate AI-driven bioprocess simulation into the latter’s food innovation infrastructure. The collaboration is intended to provide earlier-stage companies with tools to evaluate the technical and economic feasibility of scaling precision fermentation and other biomanufacturing processes.
Virtual testing before physical investment
Under the agreement, companies within Nurasa’s network will gain access to New Wave Biotech’s Bioprocess Foresight platform, which enables virtual modelling of downstream processing scenarios alongside techno-economic and life-cycle assessments. The software is designed to assess cost, yield, throughput, and environmental impact across a range of process variations, including centrifugation, filtration, and drying.
Samson Lee, Strategic Partnerships Manager at Nurasa, stated, “Singapore is strengthening its position as a hub for scalable, sustainable nutrition and biomanufacturing innovation. Integrating New Wave Biotech’s bioprocess simulation and TEA/LCA contextualisation capabilities into our platform of offerings strengthens our ability to guide both startups and corporates toward commercially viable production, not just technical validation.”
Reducing trial-and-error by over 90%
According to New Wave Biotech, the platform can reduce the need for physical experiments by over 90% and lower unit production costs by more than 50%. The goal is to provide ingredient developers and food-tech startups with more reliable data for decision-making before committing to pilot or commercial-scale manufacturing.
Nurasa, which is wholly owned by Temasek, operates a network of pilot-scale and food-grade production facilities across Asia. These include application development labs and regulatory support services intended to help food and ingredient developers move from research to market entry.
Zoe Yu Tung Law, Co-Founder and CEO of New Wave Biotech, said the partnership would help companies better understand how technical performance translates into commercial viability. “Our platform predicts technical outcomes and contextualises them through TEA and LCA, giving teams clear, data-driven insight at every stage of development. By partnering with Nurasa, we can support both startups and established companies in progressing from lab to commercially viable manufacturing with far greater clarity and lower risk.”
The collaboration is expected to support a range of projects across sustainable food categories, including fermentation-derived proteins and biomanufactured ingredients.
